Individuals Discontinuing Slimming Medications Put On Weight Far More Rapidly Compared to Dieters

A recent study indicates that individuals who discontinue popular slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who halt conventional lifestyle programs.

Research printed in a major health publication shows that while obese people can lose substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.

"People buying these treatments need to be aware of the danger of rapid rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb.

This pace of recovery suggests a return to pre-treatment weight within about 18 months.

Comparing Approaches

The analysis, which reviewed 37 of studies involving thousands of participants, compared the effects of these new drugs with older methods.

Researchers emphasize that people who shed pounds through dieting typically experience a less rapid creep back—around 100 grams monthly—post-intervention.

Understanding the Rapid Regain

Experts believe the way of the injections accounts for the accelerated rebound.

These medications imitate a body's own chemical called GLP-1, which helps regulate hunger.

"Sustained high doses of GLP-1 concentrations far above than normal could lead to the system to produce less of its endogenous hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication means hunger is unsuppressed, making overeating far more likely."

An Ongoing Condition?

Health authorities suggest the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

A number of clinicians say that, given the likelihood of relapse, the therapy is often life-long.

This view is supported by pharmaceutical companies, who note that the results "emphasize the long-term character of excess weight," similar to managing conditions like diabetes.

Patient Experiences

Users who have stopped the jabs explain a sudden resurgence of hunger.

"It felt as if a switch flipping and you become starving," described a patient.

This difficulty is exacerbated if patients have not adopted sustainable lifestyle or habit modifications during therapy.

Growing Use

Figures suggest that millions of people in the UK have tried these injections in the past year, with interest continuing to grow.

• Use is higher among females compared to males.
• The middle-aged demographic shows the highest usage rates.
• A large proportion access the drugs through private healthcare rather than the NHS.

Ultimately, experts stress that while these medications are effective tools for shedding pounds, they are not a standalone fix and maintained weight loss likely depends on ongoing behavioural changes.